Prosecution Insights
Last updated: May 29, 2026
Application No. 18/015,281

DEVICE AND METHOD FOR ESTIMATING PHYSIOLOGICAL PARAMETER VALUE, MONITORING DEVICE, AND NON-TRANSITORY COMPUTER-READABLE MEDIUM

Non-Final OA §101
Filed
Jan 09, 2023
Priority
Jul 15, 2020 — JP 2020-121471 +1 more
Examiner
SHAH, JAY B
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Nihon Kohden Corporation
OA Round
3 (Non-Final)
57%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
64%
With Interview

Examiner Intelligence

Grants 57% of resolved cases
57%
Career Allowance Rate
217 granted / 379 resolved
-12.7% vs TC avg
Moderate +7% lift
Without
With
+7.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
30 currently pending
Career history
408
Total Applications
across all art units

Statute-Specific Performance

§101
10.6%
-29.4% vs TC avg
§103
66.8%
+26.8% vs TC avg
§102
4.5%
-35.5% vs TC avg
§112
10.4%
-29.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 379 resolved cases

Office Action

§101
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 2/20/26 has been entered. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-15 rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim(s) recite(s) execute regression analysis processing based on the measured values of the first physiological parameter received by the first interface and the second physiological parameter received by the second interface until when a measured value acquired by Nth (N is an integer that is no less than n+1) measurement of the first physiological parameter is received by the first interface in order to acquire a regression equation in which the measured value of the second physiological parameter is set as an explanatory variable; calculate estimated values of the first physiological parameter with the regression equation and the measured values of the second physiological parameter received by the second interface. The abstract idea is part of the Mathematical Concepts and/or Mental Process group(s) identified in the Ninth Edition, Revision 10.2019 (revised June 2020) of the Manual of Patent Examination Procedure (MPEP). This judicial exception is not integrated into a practical application because they amount to simply implementing the abstract idea on a computer; data-gathering steps do not add a meaningful limitation to the method as they are insignificant extra-solution activity; there is no improvement to a computer or other technology; does not apply the abstract idea to effect a particular treatment or prophylaxis for a disease or medical condition; does not apply the abstract idea with, or by use of, a particular machine. The additional elements are identified as follows: estimating device with a first and second interface; a display. The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the additional elements, when considered both individually and as a whole, do not amount to significantly more than the abstract idea. The additional computer and data-gathering elements, which are recited at a high level of generality, provide conventional computer and data-gathering functions that do not add meaningful limitations to practicing the abstract idea. Those in the relevant field of art would recognize the above-identified additional elements as being well-understood, routine, and conventional means for data-gathering and computing, as demonstrated by Heravi et al. (Continuous and Cuffless Blood Pressure Monitoring Based on ECG and SpO2 Signals By Using Microsoft Visual C Sharp; J Biomed Phys Eng 2014; 4(1)). Thus, the claimed additional elements “are so well-known that they do not need to be described in detail in a patent application to satisfy 35 U.S.C. § 112(a).” Berkheimer Memorandum, III. A. 3. When considered in combination, the additional elements (generic computer functions and conventional equipment/steps) do not amount to significantly more than the abstract idea. The Federal Circuit has held that combining additional elements for data-gathering with abstract ideas does not make a claim patent-eligible. Looking at the claim limitations as a whole adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation. Regarding the dependent claims, the dependent claims are directed to either 1) steps that are also abstract or 2) additional data gathering that is well-understood, routine and previously known to the industry. Although the dependent claims are further limiting, they do not recite significantly more than the abstract idea. A narrow abstract idea is still an abstract idea and an abstract idea with additional well-known data-gathering equipment/functions is not significantly more than the abstract idea. Response to Arguments and Amendments Regarding 101 Rejections, Applicant argues that the claims represent an improvement in display of cardiovascular values as a continuous trend line is displayed with measured and estimated values. Examiner disagrees and notes that merely displaying calculated values (including interpolated/estimated values or predicted values via regression analysis) represents well known and conventional post solution activity and does not amount to a practical application. The rejection is maintained. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAY B SHAH whose telephone number is (571)272-0686. The examiner can normally be reached M-F 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at 571-272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. JAY SHAH Primary Examiner Art Unit 3791 /JAY B SHAH/ Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Show 2 earlier events
Aug 19, 2025
Response Filed
Nov 25, 2025
Final Rejection mailed — §101
Jan 30, 2026
Response after Non-Final Action
Feb 20, 2026
Request for Continued Examination
Mar 11, 2026
Response after Non-Final Action
Mar 19, 2026
Non-Final Rejection mailed — §101
May 26, 2026
Examiner Interview Summary
May 26, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12629071
METHOD FOR PROVISION OF INFORMATION ON MENTAL DISORDER AND DEVICE FOR PROVISION OF INFORMATION ON MENTAL DISORDER, USING SAME
4y 2m to grant Granted May 19, 2026
Patent 12629054
POSTURE MEASUREMENT SYSTEM FOR REALIGNMENT
2y 6m to grant Granted May 19, 2026
Patent 12622600
SYSTEM AND METHOD FOR MAINSTREAM EXHALED OXYGEN SENSOR
4y 6m to grant Granted May 12, 2026
Patent 12616801
PHLEBOTOMY AID DEVICE
4y 6m to grant Granted May 05, 2026
Patent 12616392
Devices, Methods and Kits for Biological Sample Capture and Processing
3y 7m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
57%
Grant Probability
64%
With Interview (+7.2%)
3y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 379 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month